August 24, 2022 — Patients diagnosed with moderate aortic stenosis and congestive heart failure may qualify to participate in a clinical trial that will determine whether a minimally-invasive valve replacement benefits those who are currently treated only with medication. 

August 24, 2022 — iPredict late stroke prediction model provides a fully automated prediction score for incid

August 24, 2022 —  Screening individuals for atrial fibrillation (AF) using wearable devices is more cost-effective than screening using conventional methods such as 12-lead 

When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The newer ECG devices we have now are so much less cumbersome. It’s like wearing a Band-Aid versus carrying a bulky device,” said the Greenwood, Mississippi internist. “My patients prefer the more comfortable, wire-free form factor, and the quality is as good as, or better, than the Holter,” continued Boler.

Apple created a stir when it announced in 2018 that its Apple Watch Series 4 was the first consumer health and fitness product to enable wearers to get an electrocardiogram (ECG) from their wristwatch. The device monitors the user’s heart rate and rhythm, sending notifications if abnormal findings are detected.

COVID-19 has posed challenges for physicians whose cardiac patients are at-risk and reluctant to schedule an office visit. Floyd Russak, M.D., of Russak Personalized Medicine, an internal medicine physician practicing in Greenwood Village, Colo., manages many cardiac patients who do not have ready access to a cardiologist.

Improved short-term monitoring methods for patients with stroke risk can increase early detection of atrial fibrillation (AF) and speed interventions like anticoagulation. Without anticoagulation, a person with AF may be up to five times more likely to have an ischemic stroke than someone without AF.[1] 

Advancements in Wearable ECG Technology


Arrhythmias can be described as irregular heart rhythms that are brought on by numerous factors, including heart damage, age, genetics and medications.



Like most healthcare markets, the diagnostic cardiology market has had a bumpy ride in recent years.


Subscribe Now